Merck news and events in 2026
Merck is a multinational biopharmaceutical organization that researches and develops health solutions. The organization focuses on the creation of vaccines, cancer treatments, and animal health products.
Get Merck's live signals in Claude or ChatGPT, or by API
What changed at Merck this week? Use Autobound signals for merck.com.- Dated updates
- 92
- Last event
- Oct 29, 2026
- Open rolesSnapshot Nov 3, 2026
- 207
- Latest SEC filing
- Oct 29, 2026
Source: Autobound Signal API · 92 signals tracked for Merck · updated
Overview
Merck by topic
110-K filing
207open roles
56+signals
41 in the last 90 days
- Glassdoor15+
- Website changes15+
- X (Twitter)12
- Reddit10
- and 2 more sources
Latest events
Latest Merck events
Showing 10 of 29 events. The Signal API returns all of them.
Get them with one API call- RevenueMerck tops quarterly estimates, hikes profit outlook as new form of Keytruda shows strengthMerck reported third-quarter revenue of $18.09 billion, up 5% year-over-year.
- AcquisitionMerck to Acquire Silence Therapeutics for $1.3 Billion, Expanding Rare Disease Portfolio with siRNA InnovationMerck entered into a definitive agreement to acquire Silence Therapeutics for approximately $1.3 billion in equity value.
- Facility expansionMerck Commits $2.9 Billion to Montgomery County ExpansionMerck plans to invest $2.9 billion to expand its pharmaceutical research and manufacturing operations in Montgomery County by the end of 2030.
- Facility expansionMerck unveils $500M research building at West Point campus in Montgomery CountyMerck is investing $50 million in its research and development facilities at Spring House Innovation Park in Lower Gwynedd, Pennsylvania.
- Facility expansionMerck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to makeMerck officially opened a new 120,000-square-foot research and development facility named Advance on its West Point, Pennsylvania campus.
- Executive hirePaul J. Diaz Elected to Merck BoardPaul J. Diaz, Member of the Board of Directors
- In development
- In developmentMerck reports trial results. Scotiabank raises target for Merck stockMerck & Co. reported positive phase 2b trial results for its drug candidate tulisokibart, with the high-dose group achieving a 72% response rate compared to 35% for placebo.
- In developmentMSD backs Ingenia as sole phase 3 TIE2 eye drug advances in Korea and US - CHOSUNBIZWith Ingenia Therapeutics
- LaunchMerck (MRK) Stock May Be 37% Undervalued On Fresh FDA ApprovalMerck recently received approval for its treatment WINREVAIR.
Showing 10 of 29 events. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Merck with the Signal API
One POST /v1/companies/enrich call with merck.com returns every signal type for Merck, each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Bulk data
Need these signals for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file).
Same industry
Companies related to Merck
Merck questions
What is the latest news on Merck?
What is going on with Merck?
Is Merck laying off employees?
Has Merck announced any acquisitions?
What else does Autobound track for Merck?
Is Merck hiring right now?
Page updated , the date of the newest row on this page.
Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.
Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.
Data as of .